Randomized, two-way, two-period, single injectable dose, open-label, crossover, bioequivalence study to compare Enoxa pre-filled syringes (80 mg enoxaparin sodium) versus Clexane® pre-filled syringes (80 mg enoxaparin sodium), in healthy subjects under fasting condition.

drug protocol number
21-2017
drug sponsor
MEDIS Laboratories
drug study
Enoxa / Enoxaparin
drug trial site
Saudi Ajal
drug status
Ongoing
drug phase